Cargando…
Effects on Tumor Development and Metastatic Dissemination by the NKG2D Lymphocyte Receptor Expressed on Cancer Cells
The stimulatory NKG2D lymphocyte receptor together with its tumor-associated ligands enable the immune system to recognize and destroy cancer cells. However, with dynamic changes unfolding, cancers exploit NKG2D and its ligands for immune evasion and suppression. Recent findings have added yet anoth...
Autores principales: | El-Gazzar, Ahmed, Cai, Xin, Reeves, Rebecca S., Dai, Zhenpeng, Caballero-Benitez, Andrea, McDonald, David L., Vazquez, Julio, Gooley, Ted A., Sale, George E., Spies, Thomas, Groh, Veronika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994187/ https://www.ncbi.nlm.nih.gov/pubmed/24141776 http://dx.doi.org/10.1038/onc.2013.435 |
Ejemplares similares
-
Autonomous Stimulation of Cancer Cell Plasticity by the Human NKG2D Lymphocyte Receptor Coexpressed with Its Ligands on Cancer Cells
por: Cai, Xin, et al.
Publicado: (2014) -
Normally occurring NKG2D(+)CD4(+) T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus
por: Dai, Zhenpeng, et al.
Publicado: (2009) -
Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells()()
por: Cai, Xin, et al.
Publicado: (2017) -
Soluble MICB in Plasma and Urine Explains Population Expansions of NKG2D(+)CD4 T Cells Inpatients with Juvenile-Onset Systemic Lupus Erythematosus
por: Hamada, Satoru, et al.
Publicado: (2017) -
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
por: Lu, Hailing, et al.
Publicado: (2013)